Macquarie Healthcare isn’t a compelling source of exposure to its target sector.
Nomura Healthcare Fund Class R DLRHX
- NAV / 1-Day Return 26.52 / −1.71 %
- Total Assets 751.8M
-
Adj. Expense Ratio
1.460%
- Expense Ratio 1.460%
- Distribution Fee Level Above Average
- Share Class Type Retirement, Medium
- Category Health
- Investment Style Mid Value
- Min. Initial Investment 0
- Status Open
- TTM Yield 2.20%
- Turnover 5%
USD | NAV as of Jul 11, 2026 | 1-Day Return as of Jul 11, 2026, 12:11 AM GMT+0
Morningstar’s Analysis DLRHX
Will DLRHX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 40.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
UCB SA | 5.45 | 38M | Healthcare |
Pfizer Inc | 4.27 | 30M | Healthcare |
Regeneron Pharmaceuticals Inc | 4.12 | 29M | Healthcare |
Eli Lilly and Co | 4.10 | 29M | Healthcare |
Gilead Sciences Inc | 4.03 | 28M | Healthcare |
AbbVie Inc | 3.88 | 27M | Healthcare |
UnitedHealth Group Inc | 3.80 | 27M | Healthcare |
Merck & Co Inc | 3.64 | 26M | Healthcare |
Elevance Health Inc | 3.53 | 25M | Healthcare |
AstraZeneca PLC | 3.48 | 24M | Healthcare |